vs
Ceribell, Inc.（CBLL）与Ispire Technology Inc.（ISPR）财务数据对比。点击上方公司名可切换其他公司
Ceribell, Inc.的季度营收约是Ispire Technology Inc.的1.2倍（$24.8M vs $20.3M），Ispire Technology Inc.净利率更高（-32.5% vs -54.6%，领先22.0%），Ispire Technology Inc.自由现金流更多（$-4.0M vs $-11.0M）
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业，主打便携式快速脑电图检测设备，可为急症、重症护理场景提供便捷的癫痫发作监测解决方案，核心市场覆盖北美地区，目前正逐步推进全球化业务布局。
Ispire科技是一家专注于先进雾化硬件及配套耗材研发、生产与销售的全球化科技企业，主要服务尼古丁及合法大麻消费市场，下设硬件、品牌大麻产品两大核心业务板块，覆盖北美、欧洲、亚太等核心市场，为B端合作商及终端用户提供合规创新的雾化解决方案。
CBLL vs ISPR — 直观对比
营收规模更大
CBLL
是对方的1.2倍
$20.3M
净利率更高
ISPR
高出22.0%
-54.6%
自由现金流更多
ISPR
多$6.9M
$-11.0M
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $24.8M | $20.3M |
| 净利润 | $-13.5M | $-6.6M |
| 毛利率 | 87.3% | 17.1% |
| 营业利润率 | -58.9% | -33.9% |
| 净利率 | -54.6% | -32.5% |
| 营收同比 | — | -51.5% |
| 净利润同比 | — | 17.4% |
| 每股收益（稀释后） | $-0.35 | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBLLISPR
| Q4 25 | $24.8M | $20.3M | ||
| Q3 25 | $22.6M | $30.4M | ||
| Q2 25 | $21.2M | $20.1M | ||
| Q1 25 | $20.5M | $26.2M | ||
| Q4 24 | — | $41.8M | ||
| Q3 24 | $17.2M | $39.3M | ||
| Q2 24 | — | $37.3M | ||
| Q1 24 | — | $30.0M |
净利润CBLLISPR
| Q4 25 | $-13.5M | $-6.6M | ||
| Q3 25 | $-13.5M | $-3.3M | ||
| Q2 25 | $-13.6M | $-14.8M | ||
| Q1 25 | $-12.8M | $-10.9M | ||
| Q4 24 | — | $-8.0M | ||
| Q3 24 | $-10.4M | $-5.6M | ||
| Q2 24 | — | $-3.5M | ||
| Q1 24 | — | $-5.9M |
毛利率CBLLISPR
| Q4 25 | 87.3% | 17.1% | ||
| Q3 25 | 88.3% | 17.0% | ||
| Q2 25 | 88.1% | 12.3% | ||
| Q1 25 | 87.9% | 18.2% | ||
| Q4 24 | — | 18.5% | ||
| Q3 24 | 87.3% | 19.5% | ||
| Q2 24 | — | 28.3% | ||
| Q1 24 | — | 20.4% |
营业利润率CBLLISPR
| Q4 25 | -58.9% | -33.9% | ||
| Q3 25 | -64.8% | -8.9% | ||
| Q2 25 | -70.5% | -72.7% | ||
| Q1 25 | -69.3% | -40.4% | ||
| Q4 24 | — | -17.6% | ||
| Q3 24 | -57.8% | -13.4% | ||
| Q2 24 | — | -9.2% | ||
| Q1 24 | — | -18.8% |
净利率CBLLISPR
| Q4 25 | -54.6% | -32.5% | ||
| Q3 25 | -59.6% | -10.7% | ||
| Q2 25 | -64.4% | -73.4% | ||
| Q1 25 | -62.4% | -41.5% | ||
| Q4 24 | — | -19.1% | ||
| Q3 24 | -60.6% | -14.2% | ||
| Q2 24 | — | -9.4% | ||
| Q1 24 | — | -19.7% |
每股收益（稀释后）CBLLISPR
| Q4 25 | $-0.35 | $-0.12 | ||
| Q3 25 | $-0.37 | $-0.06 | ||
| Q2 25 | $-0.38 | $-0.26 | ||
| Q1 25 | $-0.36 | $-0.19 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | $-1.85 | $-0.10 | ||
| Q2 24 | — | $-0.07 | ||
| Q1 24 | — | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $159.3M | $17.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $155.3M | $-7.7M |
| 总资产 | $195.8M | $84.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CBLLISPR
| Q4 25 | $159.3M | $17.6M | ||
| Q3 25 | $168.5M | $22.7M | ||
| Q2 25 | $177.4M | $24.4M | ||
| Q1 25 | $182.7M | $23.5M | ||
| Q4 24 | — | $34.4M | ||
| Q3 24 | $14.1M | $37.7M | ||
| Q2 24 | — | $35.1M | ||
| Q1 24 | — | $39.5M |
股东权益CBLLISPR
| Q4 25 | $155.3M | $-7.7M | ||
| Q3 25 | $164.1M | $-1.8M | ||
| Q2 25 | $172.2M | $604.7K | ||
| Q1 25 | $180.9M | $14.8M | ||
| Q4 24 | — | $24.2M | ||
| Q3 24 | $-136.0M | $30.7M | ||
| Q2 24 | — | $34.5M | ||
| Q1 24 | — | $35.9M |
总资产CBLLISPR
| Q4 25 | $195.8M | $84.4M | ||
| Q3 25 | $199.5M | $96.4M | ||
| Q2 25 | $207.7M | $102.2M | ||
| Q1 25 | $213.5M | $115.7M | ||
| Q4 24 | — | $132.0M | ||
| Q3 24 | $47.1M | $129.0M | ||
| Q2 24 | — | $122.6M | ||
| Q1 24 | — | $108.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.8M | $-4.0M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | $-4.0M |
| 自由现金流率自由现金流/营收 | -44.2% | -19.9% |
| 资本支出强度资本支出/营收 | 0.7% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.6M | $-14.2M |
8季度趋势，按日历期对齐
经营现金流CBLLISPR
| Q4 25 | $-10.8M | $-4.0M | ||
| Q3 25 | $-11.1M | $-1.2M | ||
| Q2 25 | $-7.5M | $4.7M | ||
| Q1 25 | $-11.4M | $-12.5M | ||
| Q4 24 | — | $-3.2M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | — | $-1.4M | ||
| Q1 24 | — | $3.4M |
自由现金流CBLLISPR
| Q4 25 | $-11.0M | $-4.0M | ||
| Q3 25 | $-11.5M | $-1.2M | ||
| Q2 25 | $-7.6M | $3.7M | ||
| Q1 25 | $-11.6M | $-12.7M | ||
| Q4 24 | — | $-3.2M | ||
| Q3 24 | — | $3.3M | ||
| Q2 24 | — | $-2.2M | ||
| Q1 24 | — | $3.3M |
自由现金流率CBLLISPR
| Q4 25 | -44.2% | -19.9% | ||
| Q3 25 | -50.8% | -3.9% | ||
| Q2 25 | -35.9% | 18.6% | ||
| Q1 25 | -56.4% | -48.4% | ||
| Q4 24 | — | -7.7% | ||
| Q3 24 | — | 8.5% | ||
| Q2 24 | — | -5.9% | ||
| Q1 24 | — | 10.9% |
资本支出强度CBLLISPR
| Q4 25 | 0.7% | 0.3% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 0.3% | 4.8% | ||
| Q1 25 | 0.7% | 0.7% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 0.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
ISPR
暂无分部数据
